Home ›› 10 Jan 2023 ›› Corporate
Professor Sarah Gilbert, world renowned vaccinologist and co-inventor of the Oxford-AstraZeneca Covid-19 vaccine, visited the office of Incepta Pharmaceuticals Limited in Dhaka on Monday.
Incepta Pharmaceuticals Chairman and Managing Director Abdul Muktadir and Vice Chairman Hasneen Muktadir welcomed her at Incepta head office, said a press release.
They discussed the future prospects and challenges of vaccine production in Bangladesh, availability of vaccines to common people, and the capacity of vaccine production.
Various aspects of modern and advanced technologies in vaccine production were deliberated and she gave her guidance on how Incepta can incorporate these modern technologies.
In addition, Abdul Muktadir requested to arrange high level training for vaccine development at Oxford University for the vaccine scientists of Incepta and Professor Gilbert gave her positive response. As an outcome, it is expected that these scientists working at Incepta will be able to receive higher training in vaccine development at Oxford University.
Chief Operating Officer Mahbubul Karim and Executive Director Dr EH Arefin Ahmed and many others were also present at the discussion session.
Professor Sarah Gilbert is a Professor of Vaccine Science at the Jenner Institute, Oxford and Nuffield Department of Clinical Medicine, University of Oxford.
She led the development of Oxford-AstraZeneca vaccine for Covid-19. In 2021, Professor Gilbert was awarded the prestigious Albert Medal and Damehood by the Queen Elizabeth II for her contribution to develop Oxford-AstraZeneca vaccine.